NRC National Research Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: NRC

Price (delayed)

$34.03

Market cap

$811.77M

P/E Ratio

27.01

Dividend/share

$0.48

EPS

$1.26

Enterprise value

$841.8M

NRC Health is the leading provider of in-depth customer insights in healthcare.

Highlights
The stock's price to earnings (P/E) is 26% less than its last 4 quarters average of 35.4 and 24% less than its 5-year quarterly average of 34.4
The EPS has grown by 8% since the previous quarter
The quick ratio has dropped by 55% year-on-year but it has grown by 18% since the previous quarter
NRC's net income is up by 8% QoQ but it is down by 2.6% YoY
National Research's debt has surged by 65% YoY and by 54% QoQ
National Research's equity has decreased by 32% YoY and by 15% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://nrchealth.com
Peers: NWBO

Key stats

What are the main financial stats of NRC
Market
Shares outstanding
23.85M
Market cap
$811.77M
Enterprise value
$841.8M
Valuations
Price to earnings (P/E)
27.01
Price to book (P/B)
17.07
Price to sales (P/S)
5.62
EV/EBIT
20.62
EV/EBITDA
18.02
EV/Sales
5.67
Earnings
Revenue
$148.58M
EBIT
$40.82M
EBITDA
$46.72M
Free cash flow
$22.34M
Per share
EPS
$1.26
Free cash flow per share
$0.91
Book value per share
$1.99
Revenue per share
$6.05
TBVPS
$2.42
Balance sheet
Total assets
$122.44M
Total liabilities
$73.48M
Debt
$36.68M
Equity
$48.96M
Working capital
-$11.84M
Liquidity
Debt to equity
0.75
Current ratio
0.67
Quick ratio
0.53
Net debt/EBITDA
0.64
Margins
EBITDA margin
31.4%
Gross margin
62.3%
Net margin
20.8%
Operating margin
27%
Efficiency
Return on assets
24.3%
Return on equity
47.8%
Return on invested capital
104.7%
Return on capital employed
47.3%
Return on sales
27.5%
Dividend
Dividend yield
1.41%
DPS
$0.48
Payout ratio
38.1%

NRC stock price

How has the National Research stock price performed over time
Intraday
3.53%
1 week
-0.21%
1 month
-14.69%
1 year
-23.18%
YTD
-13.98%
QTD
-14.09%

Financial performance

How have National Research's revenue and profit performed over time
Revenue
$148.58M
Gross profit
$92.57M
Operating income
$40.05M
Net income
$30.97M
Gross margin
62.3%
Net margin
20.8%
NRC's operating income is down by 14% YoY
National Research's operating margin has decreased by 12% YoY
National Research's net margin has increased by 8% QoQ
NRC's net income is up by 8% QoQ but it is down by 2.6% YoY

Growth

What is National Research's growth rate over time

Valuation

What is National Research stock price valuation
NRC P/E details
P/E
27.01
P/B
17.07
P/S
5.62
EV/EBIT
20.62
EV/EBITDA
18.02
EV/Sales
5.67
The stock's price to earnings (P/E) is 26% less than its last 4 quarters average of 35.4 and 24% less than its 5-year quarterly average of 34.4
The EPS has grown by 8% since the previous quarter
National Research's equity has decreased by 32% YoY and by 15% QoQ
NRC's price to book (P/B) is 28% less than its 5-year quarterly average of 22.8
The P/S is 35% lower than the 5-year quarterly average of 8.4 and 24% lower than the last 4 quarters average of 7.1

Efficiency

How efficient is National Research business performance
NRC's return on invested capital is down by 36% year-on-year and by 10% since the previous quarter
NRC's return on equity is up by 17% since the previous quarter and by 9% year-on-year
The return on assets has increased by 9% since the previous quarter and by 6% year-on-year
The return on sales has grown by 5% since the previous quarter but it has declined by 5% year-on-year

Dividends

What is NRC's dividend history
DPS
$0.48
Dividend yield
1.41%
Payout ratio
38.1%
Recent dividends

Financial health

How did National Research financials performed over time
NRC's total assets is 67% greater than its total liabilities
The quick ratio has dropped by 55% year-on-year but it has grown by 18% since the previous quarter
NRC's current ratio is down by 49% YoY but it is up by 10% QoQ
National Research's debt is 25% lower than its equity
NRC's debt to equity has soared by 142% YoY and by 83% QoQ
National Research's debt has surged by 65% YoY and by 54% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.